Login / Signup

Membrane-encapsulated camouflaged nanomedicines in drug delivery.

Suparna GhoshKoyeli GirigoswamiAgnishwar Girigoswami
Published in: Nanomedicine (London, England) (2019)
Owing to the limitations of conventional therapies, there has been an increasing need for nanomedicines for real-time diagnosis and effective treatment of life-threatening diseases. Despite the conceptual and technological success achieved by researchers worldwide, the complexities of biological systems, efficient engineering and formulation of monodispersed nanomedicines, inadequate information on bio-nano interactions, issues on health hazards, clinical trials and commercialization have set new challenges in biomedical research. This review highlights how the biological membrane improves the performance of nanomedicines in drug delivery. With the list of nanomedicines getting longer gradually to overcome the drawbacks of conventional therapeutics, it is important to concentrate on the interactions between nanostructures and living systems in order to improve the biocompatibility and therapeutic efficacy of functional nanomedicines.
Keyphrases
  • drug delivery
  • clinical trial
  • cancer therapy
  • healthcare
  • randomized controlled trial
  • mental health
  • combination therapy
  • health promotion